Viral Inactivation Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Viral Inactivation Market to 2027 - Global Analysis and Forecasts By Method (Solvent Detergent Method, Pasteurization, Other Methods); Product (Kits & Reagents, Services, Viral Inactivation Systems & Accessories); Application (Vaccines & Therapeutics, Blood & Blood Products, Cellular & Gene Therapy Products, Tissues & Tissue Products, Stem Cell Products); End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Other End Users) and Geography

Report Code: TIPRE00004176 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Viral inactivation is a method of viral removal process in which the viruses may remain in the final product, but in a non-infective form. Viral inactivation is used majorly in the blood plasma industry. Viral inactivation is an important part of the viral clearance process, which is compulsory for any drug development process. Various regulatory authorities such as FDA have strengthened the need for viral inactivation in various applications such as cellular & gene therapy, vaccines, therapeutics, stem cell products, tissue & tissue products, and blood & blood products.

MARKET DYNAMICS
The viral inactivation market is expected to grow during the forecast period due to fast growth in pharmaceutical & biotechnology industries, rising number of new drug launches, growing government support for pharmaceutical & biotechnology industries, and strong R&D investments in the life sciences industry. However, high degree of consolidation to act as a major barrier for new entrants and high costs associated with the manufacture of biosimilar products are likely to hamper the growth of the market in the forecast period.

MARKET SCOPE
The "Global Viral Inactivation Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of enteral feeding formulas market with detailed market segmentation by method, product, application, end user and geography. The global viral inactivation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading enteral feeding formulas market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global viral inactivation market is segmented on the basis of method, product, application, and end user. On the basis of method, the market is classified as solvent detergent method, pasteurization, and other methods. Based on product, the market is classified as kits & reagents, services, and viral inactivation systems & accessories. Based on application, the market is classified as vaccines & therapeutics, blood & blood products, cellular & gene therapy products, tissues & tissue products, and stem cell products. On the basis of end user, the market is classified as pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and other end users.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global viral inactivation market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The viral inactivation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting viral inactivation market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the viral inactivation market in these regions.

MARKET PLAYERS
The reports cover key developments in the viral inactivation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from viral inactivation market are anticipated to lucrative growth opportunities in the future with the rising demand for viral inactivation in the global market. Below mentioned is the list of few companies engaged in the viral inactivation market.

The report also includes the profiles of key viral inactivation market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Merck KGaA
  • Danaher
  • Sartorius AG
  • Charles River
  • SGS SA
  • PARKER HANNIFIN CORP
  • Clean Cells
  • Rad Source Technologies
  • Texcell
  • WuXi AppTec
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Viral Inactivation Market - By Method
1.3.2 Viral Inactivation Market - By Product
1.3.3 Viral Inactivation Market - By Application
1.3.4 Viral Inactivation Market - By End User
1.3.5 Viral Inactivation Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. VIRAL INACTIVATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VIRAL INACTIVATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VIRAL INACTIVATION MARKET - GLOBAL MARKET ANALYSIS
6.1. VIRAL INACTIVATION - GLOBAL MARKET OVERVIEW
6.2. VIRAL INACTIVATION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. VIRAL INACTIVATION MARKET - REVENUE AND FORECASTS TO 2027 - METHOD
7.1. OVERVIEW
7.2. METHOD MARKET FORECASTS AND ANALYSIS
7.3. SOLVENT DETERGENT METHOD
7.3.1. Overview
7.3.2. Solvent Detergent Method Market Forecast and Analysis
7.4. PASTEURIZATION
7.4.1. Overview
7.4.2. Pasteurization Market Forecast and Analysis
7.5. OTHER METHODS
7.5.1. Overview
7.5.2. Other Methods Market Forecast and Analysis
8. VIRAL INACTIVATION MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. KITS & REAGENTS
8.3.1. Overview
8.3.2. Kits & Reagents Market Forecast and Analysis
8.4. SERVICES
8.4.1. Overview
8.4.2. Services Market Forecast and Analysis
8.5. VIRAL INACTIVATION SYSTEMS & ACCESSORIES
8.5.1. Overview
8.5.2. Viral Inactivation Systems & Accessories Market Forecast and Analysis
9. VIRAL INACTIVATION MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. VACCINES & THERAPEUTICS
9.3.1. Overview
9.3.2. Vaccines & Therapeutics Market Forecast and Analysis
9.4. BLOOD & BLOOD PRODUCTS
9.4.1. Overview
9.4.2. Blood & Blood Products Market Forecast and Analysis
9.5. CELLULAR & GENE THERAPY PRODUCTS
9.5.1. Overview
9.5.2. Cellular & Gene Therapy Products Market Forecast and Analysis
9.6. TISSUES & TISSUE PRODUCTS
9.6.1. Overview
9.6.2. Tissues & Tissue Products Market Forecast and Analysis
9.7. STEM CELL PRODUCTS
9.7.1. Overview
9.7.2. Stem Cell Products Market Forecast and Analysis
10. VIRAL INACTIVATION MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical & Biotechnology Companies Market Forecast and Analysis
10.4. CONTRACT RESEARCH ORGANIZATIONS
10.4.1. Overview
10.4.2. Contract Research Organizations Market Forecast and Analysis
10.5. ACADEMIC RESEARCH INSTITUTES
10.5.1. Overview
10.5.2. Academic Research Institutes Market Forecast and Analysis
10.6. OTHER END USERS
10.6.1. Overview
10.6.2. Other End Users Market Forecast and Analysis
11. VIRAL INACTIVATION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Viral Inactivation Market Overview
11.1.2 North America Viral Inactivation Market Forecasts and Analysis
11.1.3 North America Viral Inactivation Market Forecasts and Analysis - By Method
11.1.4 North America Viral Inactivation Market Forecasts and Analysis - By Product
11.1.5 North America Viral Inactivation Market Forecasts and Analysis - By Application
11.1.6 North America Viral Inactivation Market Forecasts and Analysis - By End User
11.1.7 North America Viral Inactivation Market Forecasts and Analysis - By Countries
11.1.7.1 United States Viral Inactivation Market
11.1.7.1.1 United States Viral Inactivation Market by Method
11.1.7.1.2 United States Viral Inactivation Market by Product
11.1.7.1.3 United States Viral Inactivation Market by Application
11.1.7.1.4 United States Viral Inactivation Market by End User
11.1.7.2 Canada Viral Inactivation Market
11.1.7.2.1 Canada Viral Inactivation Market by Method
11.1.7.2.2 Canada Viral Inactivation Market by Product
11.1.7.2.3 Canada Viral Inactivation Market by Application
11.1.7.2.4 Canada Viral Inactivation Market by End User
11.1.7.3 Mexico Viral Inactivation Market
11.1.7.3.1 Mexico Viral Inactivation Market by Method
11.1.7.3.2 Mexico Viral Inactivation Market by Product
11.1.7.3.3 Mexico Viral Inactivation Market by Application
11.1.7.3.4 Mexico Viral Inactivation Market by End User
11.2. EUROPE
11.2.1 Europe Viral Inactivation Market Overview
11.2.2 Europe Viral Inactivation Market Forecasts and Analysis
11.2.3 Europe Viral Inactivation Market Forecasts and Analysis - By Method
11.2.4 Europe Viral Inactivation Market Forecasts and Analysis - By Product
11.2.5 Europe Viral Inactivation Market Forecasts and Analysis - By Application
11.2.6 Europe Viral Inactivation Market Forecasts and Analysis - By End User
11.2.7 Europe Viral Inactivation Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Viral Inactivation Market
11.2.7.1.1 Germany Viral Inactivation Market by Method
11.2.7.1.2 Germany Viral Inactivation Market by Product
11.2.7.1.3 Germany Viral Inactivation Market by Application
11.2.7.1.4 Germany Viral Inactivation Market by End User
11.2.7.2 France Viral Inactivation Market
11.2.7.2.1 France Viral Inactivation Market by Method
11.2.7.2.2 France Viral Inactivation Market by Product
11.2.7.2.3 France Viral Inactivation Market by Application
11.2.7.2.4 France Viral Inactivation Market by End User
11.2.7.3 Italy Viral Inactivation Market
11.2.7.3.1 Italy Viral Inactivation Market by Method
11.2.7.3.2 Italy Viral Inactivation Market by Product
11.2.7.3.3 Italy Viral Inactivation Market by Application
11.2.7.3.4 Italy Viral Inactivation Market by End User
11.2.7.4 Spain Viral Inactivation Market
11.2.7.4.1 Spain Viral Inactivation Market by Method
11.2.7.4.2 Spain Viral Inactivation Market by Product
11.2.7.4.3 Spain Viral Inactivation Market by Application
11.2.7.4.4 Spain Viral Inactivation Market by End User
11.2.7.5 United Kingdom Viral Inactivation Market
11.2.7.5.1 United Kingdom Viral Inactivation Market by Method
11.2.7.5.2 United Kingdom Viral Inactivation Market by Product
11.2.7.5.3 United Kingdom Viral Inactivation Market by Application
11.2.7.5.4 United Kingdom Viral Inactivation Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Viral Inactivation Market Overview
11.3.2 Asia-Pacific Viral Inactivation Market Forecasts and Analysis
11.3.3 Asia-Pacific Viral Inactivation Market Forecasts and Analysis - By Method
11.3.4 Asia-Pacific Viral Inactivation Market Forecasts and Analysis - By Product
11.3.5 Asia-Pacific Viral Inactivation Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Viral Inactivation Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Viral Inactivation Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Viral Inactivation Market
11.3.7.1.1 Australia Viral Inactivation Market by Method
11.3.7.1.2 Australia Viral Inactivation Market by Product
11.3.7.1.3 Australia Viral Inactivation Market by Application
11.3.7.1.4 Australia Viral Inactivation Market by End User
11.3.7.2 China Viral Inactivation Market
11.3.7.2.1 China Viral Inactivation Market by Method
11.3.7.2.2 China Viral Inactivation Market by Product
11.3.7.2.3 China Viral Inactivation Market by Application
11.3.7.2.4 China Viral Inactivation Market by End User
11.3.7.3 India Viral Inactivation Market
11.3.7.3.1 India Viral Inactivation Market by Method
11.3.7.3.2 India Viral Inactivation Market by Product
11.3.7.3.3 India Viral Inactivation Market by Application
11.3.7.3.4 India Viral Inactivation Market by End User
11.3.7.4 Japan Viral Inactivation Market
11.3.7.4.1 Japan Viral Inactivation Market by Method
11.3.7.4.2 Japan Viral Inactivation Market by Product
11.3.7.4.3 Japan Viral Inactivation Market by Application
11.3.7.4.4 Japan Viral Inactivation Market by End User
11.3.7.5 South Korea Viral Inactivation Market
11.3.7.5.1 South Korea Viral Inactivation Market by Method
11.3.7.5.2 South Korea Viral Inactivation Market by Product
11.3.7.5.3 South Korea Viral Inactivation Market by Application
11.3.7.5.4 South Korea Viral Inactivation Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Viral Inactivation Market Overview
11.4.2 Middle East and Africa Viral Inactivation Market Forecasts and Analysis
11.4.3 Middle East and Africa Viral Inactivation Market Forecasts and Analysis - By Method
11.4.4 Middle East and Africa Viral Inactivation Market Forecasts and Analysis - By Product
11.4.5 Middle East and Africa Viral Inactivation Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Viral Inactivation Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Viral Inactivation Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Viral Inactivation Market
11.4.7.1.1 South Africa Viral Inactivation Market by Method
11.4.7.1.2 South Africa Viral Inactivation Market by Product
11.4.7.1.3 South Africa Viral Inactivation Market by Application
11.4.7.1.4 South Africa Viral Inactivation Market by End User
11.4.7.2 Saudi Arabia Viral Inactivation Market
11.4.7.2.1 Saudi Arabia Viral Inactivation Market by Method
11.4.7.2.2 Saudi Arabia Viral Inactivation Market by Product
11.4.7.2.3 Saudi Arabia Viral Inactivation Market by Application
11.4.7.2.4 Saudi Arabia Viral Inactivation Market by End User
11.4.7.3 U.A.E Viral Inactivation Market
11.4.7.3.1 U.A.E Viral Inactivation Market by Method
11.4.7.3.2 U.A.E Viral Inactivation Market by Product
11.4.7.3.3 U.A.E Viral Inactivation Market by Application
11.4.7.3.4 U.A.E Viral Inactivation Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Viral Inactivation Market Overview
11.5.2 South and Central America Viral Inactivation Market Forecasts and Analysis
11.5.3 South and Central America Viral Inactivation Market Forecasts and Analysis - By Method
11.5.4 South and Central America Viral Inactivation Market Forecasts and Analysis - By Product
11.5.5 South and Central America Viral Inactivation Market Forecasts and Analysis - By Application
11.5.6 South and Central America Viral Inactivation Market Forecasts and Analysis - By End User
11.5.7 South and Central America Viral Inactivation Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Viral Inactivation Market
11.5.7.1.1 Brazil Viral Inactivation Market by Method
11.5.7.1.2 Brazil Viral Inactivation Market by Product
11.5.7.1.3 Brazil Viral Inactivation Market by Application
11.5.7.1.4 Brazil Viral Inactivation Market by End User
11.5.7.2 Argentina Viral Inactivation Market
11.5.7.2.1 Argentina Viral Inactivation Market by Method
11.5.7.2.2 Argentina Viral Inactivation Market by Product
11.5.7.2.3 Argentina Viral Inactivation Market by Application
11.5.7.2.4 Argentina Viral Inactivation Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. VIRAL INACTIVATION MARKET, KEY COMPANY PROFILES
13.1. MERCK KGAA
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. DANAHER
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. SARTORIUS AG
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CHARLES RIVER
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. SGS SA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PARKER HANNIFIN CORP
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. CLEAN CELLS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. RAD SOURCE TECHNOLOGIES
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. TEXCELL
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. WUXI APPTEC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Merck KGaA
2. Danaher
3. Sartorius AG
4. Charles River
5. SGS SA
6. PARKER HANNIFIN CORP
7. Clean Cells
8. Rad Source Technologies
9. Texcell
10. WuXi AppTec
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book